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Abstract 
Equine metabolic syndrome (EMS) it’s a clinical condition that includes obesity, regional 
adiposity, insulin resistance (IR) and laminitis. A similar syndrome exists in human medi-
cine, the metabolic syndrome (MS), were systemic hypertension also is a prominent fea-
ture. The systemic hypertension seen in humans with MS is partly due to a vascular endo-
thelial dysfunction with an enhanced endothelin-1 (ET-1) mediated vasoconstriction. There 
are indications that systemic hypertension might be a feature in EMS as well but if ET-1 is 
involved in the development of the systemic hypertension in horses is not known. In-
creased circulating cortisol levels have also been found in humans with MS. To our 
knowledge, there are no studies that have measured serum cortisol concentrations in horses 
diagnosed with EMS, and the question remain whether horses with EMS differ in cortisol 
concentrations compared to controls. Before blood pressure, plasma ET-1 and serum corti-
sol can be evaluated in horses with EMS, it is necessary to test the day-to-day variation of 
these parameters on clinically healthy horses.  
The aim of the present study was to evaluate the day-to-day variation of indirect oscil-
lometric blood pressure measurements, plasma ET-1 and serum cortisol concentrations in 
healthy Standardbred and Icelandic horses, and to detect any potential breed differences in 
theses parameters. Additional aims were to study if transportation could influence the re-
sults obtained and to compare the two indirect blood pressure measurement devices, the 
Cardell
® 
Veterinary Vital Signs Monitor (Cardell) Model 9402, and the HDO Memo Diag-
nostic (HDO) horse model 1.35.00. 
Nine horses of each breed were included in the study. Blood pressure was measured and 
blood samples were collected between 6 and 9 am on two separate days. Eight of the hors-
es (four Standardbred horses, four Icelandic horses) were transported to a new stable were 
they stayed overnight. On the morning after the transportation, the blood pressure meas-
urements and the sampling procedure were repeated. 
The results showed that indirect blood pressure measurements, plasma ET-1 and serum 
cortisol all had an acceptable day-to-day variation. There were no differences in mean 
blood pressure between the two breeds but the Icelandic horses had significantly lower 
mean serum cortisol and significantly higher mean plasma ET-1 concentrations compared 
to the Standardbred horses. Plasma ET-1 was significantly elevated after transportation, 
but the mean serum cortisol and mean blood pressure did not differ from the values ob-
tained in the home environment. 
The results indicate an acceptable day-to-day variation of the tested parameters, but the 
higher plasma ET-1 concentrations recorded after transportation, might have been caused 
by a stress response associated with the transportation and being housed in a new environ-
ment. The differences detected in plasma ET-1 and serum cortisol between the two breeds 
might be related to differences in genetic setup, training status as well as management 
conditions. The tested parameters are all potential candidates for further investigation in 
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horses clinically affected of EMS and a further evaluation of possible breed differences in 
the tested parameters is desirable. 
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Sammanfattning 
Equint metabolt syndrom (EMS) innefattar kliniska symptom såsom regional och generell 
fetma, insulinresistens (IR) och fång. Ett liknande syndrom finns inom humanmedicinen, 
metabolt syndrom (MS), där även systemisk hypertension är en del i sjukdomsbilden. Den 
systemiska hypertensionen som ses hos människor beror delvis på vaskulär dysfunktion 
med en ökad endothelin-1-medierad (ET-1) vasokonstriktion. Det finns indikationer på att 
systemisk hypertension även kan vara en del i EMS, men om ET-1 medverkar till syste-
misk hypertension på häst är i dagsläget inte utrett. Ökade nivåer av kortisol i cirkulationen 
har hittats hos människor med MS. Vad vi vet finns det inga studier som har mätt serum-
kortisolkoncentrationen hos hästar diagnostiserade med EMS, så frågan kvarstår huruvida 
dessa hästar skiljer sig i kortisolkoncentration jämfört med kontroller. Innan blodtryck, 
plasma-ET-1 och serumkortisol kan mätas hos hästar med EMS är det nödvändigt att ut-
värdera dag-till-dagvariationen hos dessa parametrar hos kliniskt friska hästar. 
Syftet med denna studie var att utvärdera dag-till-dagvariationen hos indirekt oscilomet-
risk blodtrycksmätning, plasma-ET-1 och serumkortisol hos friska varmblodstravare och 
islandshästar, samt att hitta eventuella rasvariationer i dessa parametrar. Ytterligare syften 
var att studera huruvida transport kan påverka resultaten av parametrarna samt att jämföra 
två indirekta blodtrycksmaskiner, Cardell
® 
Veterinary Vital Signs Monitor (Cardell), mo-
dell 9402, och HDO Memo Diagnostic (HDO), hästmodell 1.35.00. 
Nio hästar av varje ras deltog i studien. Blodtryck mättes och blodprov samlades in mel-
lan klockan 6-9 på morgonen under två separata provtagningsdagar. Åtta av hästarna (fyra 
varmblodstravare och fyra islandshästar) blev även transporterade till och tillbringade nat-
ten i ett för dem nytt stall. På morgonen efter transporteringen mättes åter blodtrycket och 
blodprov samlades in. 
Resultaten visade att indirekt blodtrycksmätning, plasma-ET-1- och serumkortisolkon-
centration hade en acceptabel dag-till-dagvariation. Det var inga skillnader i medelblod-
tryck mellan raserna men islandshästarna hade signifikant lägre medelkortisolkoncentrat-
ion och signifikant högre medelkoncentration av plasma-ET-1 jämför med varmblodstra-
varna. Plasma-ET-1 var signifikant höjt efter transportering medan medelserumkortisol 
och medelblodtryck inte skilde sig från värden uppmätta i hemmiljö. 
Studien visar en acceptable dag-till-dagvariation av de testade parametrarna. Den för-
höjda ET-1-koncentrationen efter transport kan ha orsakats av stress associerat med trans-
porten och vistelsen i ny miljö. Skillnaderna som upptäcktes i plasma-ET-1- och serumkor-
tisolkoncentration mellan de båda raserna kan vara relaterat till genetiska olikheter, olika 
träningsstatus eller vara skötselrelaterade. Testade parametrar är alla potentiella kandidater 
för vidare utvärdering hos hästar med EMS samt att vidare undersökningar rörande 
rasskillnader vore önskvärt. 
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1 Introduction 
Equine metabolic syndrome (EMS) was introduced in veterinary medicine in 
2002. It’s a clinical condition that includes certain parameters such as obesity, re-
gional adiposity, insulin resistance (IR) and clinical or subclinical laminitis (John-
son, 2002; Frank et al. 2010). A similar syndrome exists in human medicine; the 
metabolic syndrome (MS) which is characterized by IR, abdominal obesity, lipid 
disorders, coagulopathies, hyperglycemia and systemic hypertension (Fulop et al. 
2006). There are indications that the systemic hypertension might be a feature in 
EMS as well, as ponies with EMS and a previous history of laminitis have been 
shown to have elevated systemic blood pressure (Bailey et al. 2008). These ponies 
had a significantly elevated mean blood pressure during summer compared to con-
trols. The systemic hypertension seen in obese MS patients with IR is partly due to 
vascular endothelial dysfunction (Reaven, 2005). In this group of patients the pro-
duction of the vasodilator nitric oxide is decreased (Stuhlinger et al. 2002) and 
they have an enhanced endothelin (ET-1) mediated vasoconstriction (Cardillo et 
al. 2004). ET-1 is a potent vasoconstrictor (Levin, 1995; Katz et al. 2003) and has 
been proposed as a mediator involved in laminitis (Katwa et al. 1999). Elevated 
ET-1 concentrations have earlier been found in horses with clinical endotoxaemia 
(Menzies-Gow et al. 2005) and in horses with summer pasture-associated recur-
rent airway obstruction (SPA-RAO) (Costa et al. 2009). If ET-1 is involved in the 
development of the seasonal hypertension reported in ponies is not known, as 
there are no studies that describe plasma ET-1 levels in horses diagnosed with 
EMS. There are different blood pressure measurement devices available on the 
market for measurement of indirect systemic oscillometric blood pressure in hors-
es and the type of device used also has an effect on the blood pressure values ob-
tained (Mitchell et al. 2010). 
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The overlap between MS and Cushings´s disease in humans has raised the ques-
tion if elevated cortisol levels are associated with the development MS (Walker 
2006; Anagnostis et al. 2009). There are studies that have shown that patients with 
MS have higher circulating concentrations of cortisol, but also studies that have 
failed to find this relationship (Maggio et al. 2007). To our knowledge there are no 
studies that have measured serum cortisol concentrations in horses diagnosed with 
EMS, and the question remains whether horses with EMS differ in cortisol con-
centration compared to controls. Before further investigation of these parameters 
is indicated, the reproducibility of these parameters must be evaluated. 
Cortisol concentrations are known to have a circadian rhythm in horses (Irvine 
et al. 1994) and transportation is known to alter the normal rhythm both during 
and up to approximately 11 hours after transportation (Forhead et al. 1995). The 
diagnostic test often used to detect horses suffering from EMS is a combined glu-
cose and insulin tolerance test (CGIT-test) (Eiler et al. 2005; Frank et al. 2010) 
and this is usually performed in a clinical setting. The stress response that the 
transportation to the clinic and the new environment might cause, could affect not 
only cortisol concentrations, but also the results of all other tests used for diagnos-
ing the disease.  
1.1 The aims of the study 
This prospective experimental study aims to: 
 
 Evaluate the day-to-day variation of systemic indirect blood pressure 
measurements in standing Standardbred and Icelandic horses without 
clinical signs of disease and compare two indirect oscillometric blood 
pressure measurement devices. 
 Evaluate the day-to-day variation of plasma ET-1 and serum cortisol con-
centrations in Standardbred and Icelandic horses without clinical signs of 
disease. 
 Study if there exist any differences in systemic blood pressure, plasma 
ET-1 and serum cortisol concentrations between the two breeds. 
 Study the possible influence of transportation and housing in a new envi-
ronment on systemic blood pressure, plasma ET-1 and serum cortisol 
concentrations. 
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2 Material and Methods 
2.1 Horses 
None of the horses included in the study showed any signs of disease on the clini-
cal examination that was performed before the start of the study. BCS (Henneke et 
al. 1983) and Cresty Neck Score (CNS) (Carter et al. 2009) were estimated for 
each horse. The study was sanctioned by the Ethical Committee for Animal Exper-
iments, Uppsala, Sweden. 
2.1.1 Standardbred horses 
Nine Standardbred horses, seven mares and two geldings, with a mean age of 13 ± 
5 years (range 6-20) and with a mean body weight of 505 ± 48 kg (range 425-586), 
were included in the study. All horses were owned by the Department of Clinical 
Science and kept in box stalls with a daily stay in a paddock. All were sedentary 
horses and fed a standardized diet consisting of hay (three times/day) and concen-
trate (once daily) and provided water ad libitum. 
2.1.2 Icelandic horses 
Nine Icelandic horses, seven mares and two geldings, with a mean age of 14 ± 3 
years (range 10-18) and with a mean body weight of 381 ± 35 kg (range 333-444), 
were included in the study. All horses were privately owned and were mainly kept 
in loose outside housing but were also kept in box stalls on a regular basis. Eight 
of the horses performed lighter exercise three to five times a week and one horse 
was sedentary. These horses were fed grass haylage (three times/day) and provid-
ed water ad libitum. 
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2.1.3 Horses in the transportation study 
Four of the Standardbred horses (three mares and one gelding) and four of the Ice-
landic horses (two mares and two geldings) were included in the transportation 
study. The horses were not accustomed to transportation. 
2.2 Blood pressure measurement devices 
Cardell
® 
Veterinary Vital Signs Monitors model 9402, and The Memo Diagnostic 
High Definition Oscillometry Monitor
1
, horse model 1.35.00 were used in the 
study.  
Both devices automatically inflate an occluding cuff and use the oscillometric 
measurement technique for determination of systolic, diastolic, mean arterial 
blood pressure and heart rate. The cuff width for the Cardell device was 11 cm and 
for the HDO 8 cm. The same cuff size accompanied each device through all meas-
urements.  
2.3 Experimental design 
2.3.1 Day-to-day variation 
The blood pressure measurements and the sample collection were performed be-
tween Mars and April 2011, before the horses had access to summer pasture. 
The systemic blood pressure was measured between 6 and 9 am on two separate 
days (M1 and M2) with a maximum of one day between measurements. The cuffs 
were placed on the base of the horse’s tail while the horse was standing in the box 
stall. Five consecutive determinations of systolic and diastolic blood pressure were 
performed on each horse, using both devices. On the first day of the study, the 
starting order in which of the two blood pressure measurement devices were used 
was randomized by raffle. The next day the starting orders of the devices were 
switched. In each horse, blood samples were drawn immediately after both blood 
pressure measurements had been completed. 
2.3.2 Transportation study 
The horses were transported in a two-horse trailer for one hour and the horses 
were then housed in a new environment overnight. The next morning, the blood 
                                                     
1 MD; S + B medVetGmbH, Babenhausen, Germany 
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pressure was measured and blood samples collected (M3) in the same manner as 
previously described. 
2.3.3 Blood collection and analysis 
Blood samples for analysis of plasma ET-1 and serum cortisol were drawn using 
vacutainer technique and collected in evacuated NaEDTA
2
 and Serum
3
 glass 
tubes. The blood samples were drawn immediately after the blood pressure meas-
urements had been completed on each horse. All samples were kept on ice and 
centrifuged (+4°C, 906g, 10 min) within 30 minutes after sampling. Plasma and 
serum were separated into Ependorff tubes and then stored in -80°C until analysis.  
Plasma ET-1 concentrations were measured in duplicates using a commercial 
ELISA-kit
4
 that has previously been validated for use in horses
5
 and serum cortisol 
concentrations (hydrocortisone Compound F) were measured in duplicates with a 
radioimmunoassay-kit
6
 that also has been validated for use in horses
7
.
 
2.4 Statistical analysis 
In each horse, the lowest and highest recorded value of the five consecutive blood 
pressure determinations were excluded and the mean systolic and diastolic pres-
sure was calculated from the three remaining determinations (triplicates). The sta-
tistical analysis was performed using SigmaPlot software version 11
8
. 
The results of repeated tests for indirect blood pressure measurement, plasma 
ET-1 and serum cortisol were compared by use of a paired t-test (M1 and M2) or 
one way repeated measures analyses of variance (M1, M2, and M3; transportation 
study). Differences between individual means for the three days were tested with a 
tukey test. Differences in the two breeds for measurement of indirect blood pres-
sure measurement, plasma ET-1 and serum cortisol were compared by use of a t-
test whereas differences between the blood pressure measurement devices were 
compared by use of a paired t-test. Measurement error, defined as the variation 
between measurement of the same quantity on the same animal, blood pressure 
                                                     
2 BD, Vacutainer, BD, Belliver, Industrial Estate, Plymouth, UK  
3 BD, Vacutainer, BD, Belliver, Industrial Estate, Plymouth, UK 
4 Endothelin (1-21) enzyme immunoassay CAT.NO.BI-20052 (12*8) Biomedica Medizinprodukte 
GmbH & Co KG, A-1210 Wien 
5 Biomedica Medizinprodukte GmbH & Co KG, A-1210 Wien 
6 Coat-A-Count® Cortisol, TKCO2, SIEMENS 
7 Department of clinical chemistry, Swedish University of Agricultural Sciences, Uppsala 
8 Systat Software UK Limited, London, UK 
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device and ELISA- and radioimmunoassay-kit, was expressed as the coefficient of 
variation (CV). The standard deviation for duplicate or triplicate measurements 
was calculated according to Bland (2000). The CV was calculated as the SD di-
vided by the means of each set of two or three measurements and expressed in 
percentage.  
Mean values were expressed as mean ± SD. The level of significance was set at 
P < 0.05.  
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3 Results 
 
3.1 Body condition score and cresty neck score 
The BCS ranged from 5 to 6 in the Standardbred horses, and from 5 to 7 in the 
Icelandic horses. The CNS ranged from 1 to 2 in the Standardbred horses and from 
2 to 3 in the Icelandic horses.  
3.2 Day-to-day variation 
Regardless of which blood pressure measurement device that was used, there was 
no difference in mean systolic or diastolic blood pressure between M1 and M2.  
There was no significant difference between M1 and M2 in the mean concentra-
tion of plasma ET-1 and serum cortisol. One Icelandic horse had plasma ET-1 
concentrations that were regarded as unreasonably high (16.41 and 14.59 pg/ml) 
and another Icelandic horse showed a great variation in plasma ET-1 concentra-
tions between measurements (3.09 and 14.54 pg/ml). These values were therefore 
excluded from the calculations of plasma ET-1. One of these horses took part in 
the transportation study, and the ET-1 values of this horse were excluded because 
of concentrations above the detection limit. The intra-assay CV for plasma ET-1 
was 6.7% and the intra-assay CV for serum cortisol was 5.7%. The intra-assay 
CV´s for the Cardell device were 5.4% in systole and 13.9% in diastole and the 
intra-assay CV´s for the HDO device were 9.5 % in systole and 12.1 % in diastole.  
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3.2.1 Comparison of blood pressure measurement devices 
The mean systolic blood pressure differed significantly between the two devices 
(HDO, 114 ± 14 mmHg; Cardell, 104 ± 12 mmHg), but not the mean diastolic 
blood pressure (HDO, 71 ± 11 mmHg; Cardell, 65 ± 13 mmHg). The inter-assay 
CV was better in systole compared to in diastole for both devices. The Cardell 
showed a better inter-assay CV in systole than the HDO, but there was no differ-
ence between the two devices in diastole.  
 
Tabell 1. Day-to-day variation. Mean (±SD) values for systemic, systolic and diastolic blood pres-
sure (measured with the HDO and the Cardell device), plasma ET-1 and serum cortisol concentra-
tion measured on two separate days (M1 and M2). P < 0.05. No significant differences between M1 
and M2 were detected for any of the variables. 
    
Variable M1 M2 CV % 
HDO         
 BPS (mmHg) 114 ± 14 113 ± 18 15 
 BPD (mmHg) 71 ± 11 67 ± 15 21 
Cardell      
 
BPS (mmHg) 104 ± 12 102 ± 10 8 
BPD (mmHg) 65 ± 13 60 ± 10 19 
ET-1  (pg/ml) 2.3 ± 1.4 2.7 ± 2.0 37 
Cortisol (nmol/l) 129 ± 76 126  ± 81 18 
BPS -systolic blood pressure, BPD –diastolic blood pressure, CV -Coefficient of variation. n=18, 
except for in M1 and M2 in the ET-1 measurement where n=16. 
3.3 Breed comparison 
Regardless of which blood pressure measurement device that was used, there was 
no difference in mean systolic or diastolic blood pressure between the two breeds.   
Mean concentrations of plasma ET-1 and serum cortisol both differed signifi-
cantly between the two breeds with the Icelandic horses having significantly high-
er plasma ET-1 concentrations and significantly lower serum cortisol concentra-
tions compared to the Standardbred horses. 
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Tabell 2. Breed comparison. Mean (±SD) values for systemic, systolic and diastolic blood pressure 
(measured with the HDO and the Cardell device), plasma ET-1 and serum cortisol concentration 
measured in two different breeds (Standardbred horses and Icelandic horses). * P < 0.05 versus 
Standardbred horses.  
   
Variable Standardbred horses Icelandic horses 
HDO   
 
BPS (mmHg) 118 ± 17 110 ± 11 
BPD (mmHg) 74 ± 11 67 ± 11 
Cardell    
 
BPS (mmHg) 103 ± 9 105 ± 14 
BPD (mmHg) 64 ± 7 66 ± 17 
ET-1 (pg/ml) 1.5 ± 0.5 3.2 ± 1.7* 
Cortisol (nmol/l) 188 ± 63 70 ± 22* 
BPS -systolic blood pressure, BPD –diastolic blood pressure. n=9, except for in the Icelandic horses 
in the ET-1 measurement where n=7. 
 
3.4 Influence of transportation 
Transportation and housing in a new environment did not affect the mean systolic 
or diastolic blood pressure or mean serum cortisol concentration. 
The mean plasma ET-1 concentration was significantly higher when measured 
after transportation compared to in the home environment. 
Tabell 3. Influence of transportation. Mean (±SD) values for systemic, systolic and diastolic blood 
pressure (measured with the HDO), plasma ET-1 and serum cortisol concentration measured on two 
separate days (M1 and M2) and after transportation (M3). *P < 0.05 versus MI and M2.   
     
Variable M1 M2 M3 CV % 
HDO     
 
BPS (mmHg) 114 ± 6 110 ± 11 119 ± 10 6 
BPD (mmHg) 71 ± 6 67 ± 9 75 ± 7 9 
ET-1 (pg/ml) 1.7 ± 0.9 1.7 ± 0.9 2.6 ± 1.2* 31 
Cortisol (nmol/l) 113  ± 60 115  ± 74 122 ± 35 33 
BPS -systolic blood pressure, BPD –diastolic blood pressure, CV -Coefficient of variation. n=8, ex-
cept for in M1, M2 and M3 in the ET-1 measurement where n=7. 
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4 Discussion 
The results of the present study showed that all the parameters showed an accepta-
ble day-to- day variation and are therefore of interest as markers to study the car-
diovascular aspects of EMS. Systemic blood pressure did not differ between the 
two breeds and both blood pressure measurement devices gave values with an ac-
ceptable day-to-day variation.  
The indirect oscillometric blood pressure technique has been found to overesti-
mate the systolic blood pressure in dogs compared to the direct blood pressure 
technique (Geddes et al. 1982; Meyer et al. 2010). However, if the clinician is 
aware of the possible risk that indirect blood pressure measurement techniques 
might overestimate the blood pressure, the risk of falsely diagnosing hypertension 
in horses appears to be little. In the present study, the HDO device gave higher 
values in systole compared to the Cardell device. This could partly be related to 
the difference in cuff size between the two devices. The size of the cuff is known 
to influence the obtained blood pressure values were a cuff that is too wide under-
estimates the blood pressure whereas a cuff that is too narrow tends to overesti-
mate the values. The optimum cuff width for horses is one-fifth of the tail circum-
ference (Latshaw et al. 1979). It is therefore important that the cuff used is adjust-
ed for each type of horse. Considering the results from the presents study, both 
devices can be used to measure systemic blood pressure in Standardbred as well as 
Icelandic horses. However, there are results that indicate that the HDO device has 
a better correlation with the direct blood pressure measurement technique com-
pared to the Cardell device (Mitchell et al. 2010). A previous study in dogs also 
showed that although the blood pressure values obtained with the HDO device 
showed a greater variability than the values obtained with the direct blood pressure 
measurement technique, there was a good correlation between the two techniques 
(Meyer et al. 2010). Both devices can be run on battery, which makes it possible 
to use them during field conditions. The results from our study showed that the 
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Cardell device showed a less day-to-day variation in systole compared to the HDO 
device. However, the Cardell device is large and impractical to handle in a field 
setting whereas the HDO device is smaller in size, lighter and can be handled us-
ing only one hand. The previously reported high sensitivity and good correlation 
with the direct blood pressure measurement technique for the HDO device is also 
advantageous.  
 
As previously stated, the day-to-day variation for plasma ET-1 and serum cortisol 
was acceptable with no statistical significance detected between measurements in 
the home environment, although both parameters showed quite high inter-assay 
CV´s. The latter could be explained by the normal individual day-to-day fluctua-
tions that have earlier been reported for cortisol, triglycerides, thyroxine, proteins 
and enzymes in serum of healthy humans (Statland et al. 1976), as well as for glu-
cose and insulin in plasma of clinically healthy horses (Bröjer et al. unpublished 
data). The high SD´s seen in the day-to-day variation in serum cortisol and plasma 
ET-1 are likely related to the differences in mean values between the two breeds, 
individual fluctuations within the different breeds and the merged calculation of 
those in the day-to-day comparison.  
The mean concentration of plasma ET-1 measured in the present study was 
higher for both breeds compared to the concentrations reported earlier in healthy 
Thoroughbred and Standardbred horses (McKeever et al. 1999; Menzies-Gow et 
al. 2004) but similar range to those reported in horses with SPA-RAO (Costa et al. 
2009) and horses with clinical endotoxaemia (Menzies-Gow et al. 2005). It cannot 
be ruled out that some of the horses in the present study could have suffered from 
a disease causing an elevation in plasma ET-1. This is however considered unlike-
ly as none of the horses included in the study showed any signs of disease on the 
clinical examination that was performed before the start of the study. A more like-
ly explanation for this discrepancy in results between studies are differences in 
type of analyzing technique (ELISA) for quantification of ET-1 as well as genetic 
differences between breeds. 
 
An interesting finding was the difference in plasma ET-1 and serum cortisol con-
centrations between the two breeds. The results of the present study showed that 
the Icelandic horses had significantly higher plasma ET-1 concentrations than the 
Standardbred horses. There was a considerable individual variation in the concen-
trations of plasma ET-1 in both breeds, which is in agreement with previous stud-
ies in both healthy horses and horses affected of SPA-RAO (Costa et al. 2009). 
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However, the individual variation was greater in among the Icelandic horses which 
is verified by the higher SD value seen in this group. The reason for this difference 
between breeds is not known, but might be related to both genetic differences as 
well differences in management.  
Previous studies in ponies and Icelandic horses have reported that they are par-
tially insulin resistant (Rijnen et al. 2003; Jeffcott et al. 1986; Bröjer et al. un-
published data). In a healthy individual, insulin stimulates the production of nitric 
oxide as well as ET-1, resulting in vasodilation. In an individual with IR or hyper-
insulinemia the production of nitric oxide is decreased and the insulin-mediated 
vasodilation is therefore impaired (Pantelis et al. 2007). This could also explain 
the higher ET-1 values seen in the Icelandic horses compared to the Standardbred 
horses, as elevated insulin levels could cause an increase in ET-1 concentration 
(Piatti et al.1996). In the present study, the higher ET-1 levels in the Icelandic 
horses did not reflect any elevation in the systemic blood pressure compared to the 
Standardbred horses.  
 
In horses, cortisol production has a circadian rhythm with peak levels in the early 
morning and a nadir at night (Stull et al. 1988; Irvine et al. 1995). Because of the 
circadian rhythm sampling results are also influenced by sampling time (Irvine et 
al. 1994). Investigation of cortisol in untrained Standardbred horses in home envi-
ronment showed a circadian rhythm with a peak between 6 and 9 am (Irvine et al. 
1994), and according to these results, the horses in the present study were sampled 
at the time of peak cortisol concentration. The circadian rhythm can easily be abol-
ished by any disturbances like fasting and removal from the accustomed environ-
ment (Irvine et al. 1994; Forhead et al. 1995).  
The Icelandic horses in the present study had significantly lower concen-
trations of plasma cortisol than the Standardbred horses. The concentrations meas-
ured in the Icelandic horses, are similar to the concentrations measured in Iceland-
ic horses in an earlier study (Ragnarsson et al. 2011). In that study, no differences 
in the concentrations of serum cortisol could be detected between Standardbred 
and Icelandic horses feed the same diet (Ragnarsson et al. 2011). Our groups of 
horses were not feed the same diet, but previous research have failed to prove any 
impact of different diets on cortisol concentrations in horses (Stull et al. 1988). 
The mean concentration of cortisol of the sedentary Standardbred horses in the 
present study is in good agreement with the mean concentration previously report-
ed in well trained cross-bred trekking horses (Medica et al. 2010) indicating that 
the differences in cortisol concentrations must be influenced by other factors than 
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fitness status. Chronic inflammation is known to depress cortisol concentrations in 
horses (Mills et al. 1997) and systemic inflammation is an important component of 
EMS (Vick et al. 2007). The lower mean cortisol concentrations shown in the Ice-
landic horses in the present study could be related to breed differences, partial IR 
and/or possible subclinical systemic inflammation or be management dependent.  
 
After transportation and exposure to a new environment, plasma ET-1 concentra-
tions differed significantly compared to the concentrations measured in the home 
environment. This could be related to a prolonged stress reaction caused by the 
transportation in combination with spending the night in a new environment. This 
is supported by the fact that a previous study in horses has shown that ET-1 con-
centrations increase post-exercise, but return to baseline after 10 minutes of recov-
ery (McKeever et al. 2002). No significant difference was detected in the mean 
cortisol concentrations in the transportation study compared to the measurement in 
the home environment. This is in contrast to findings from a previous study, were 
higher serum cortisol levels were found in horses that had been transported com-
pared to a group of non-transported horses (Medica et al. 2010). In a study on 
donkeys it was noted that transportation altered the normal rhythm of resting corti-
sol to an increased rate of continuous secretion in both fed and fasted animals. The 
cortisol concentration decreased after transportation and a circadian rhythm was 
reestablished 8.5-10.5 hours later (Forhead et al. 1995). The reason for this dis-
crepancy in results could be related to differences in sampling time. The horses in 
the present study spent a minimum of 12 hours in the new box stalls before the 
sample collection took place which might have been long enough for the pulsatile 
secretion of cortisol to reestablish (Forhead et al. 1995; Schmidt et al. 2010). In 
the study by Medica et al. (2010), the sample collection was carried out the same 
day as the transportation and the time interval between transportation and sam-
pling might have been too short for a reestablishment of the pulsatile secretion. It 
is also possible that the results would have been different if we had measured a 
metabolite of cortisol in feces post-transportation as a previous study has shown 
significantly elevated levels of this metabolite one day post-transport (Schmidt et 
al. 2010). However, the results of the present study indicate that serum cortisol 
and indirect blood pressure can be measured with reliable results if samples are 
collected at least 12 hours post-transportation.  
 
The significant difference in the concentrations of ET-1 and cortisol between the 
two breeds was not reflected in any differences in blood pressure. The previously 
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reported systemic hypertension in laminitis-prone ponies was detected in the 
summer (Bailey et al. 2008). The blood pressure measurements in the present 
study were recorded during the winter. It would therefore be of interest to measure 
blood pressure as well as plasma ET-1 and serum cortisol on Icelandic- and Stand-
ardbred horses over the whole year to be able to detect potential seasonal varia-
tions and breed related differences.  
Previous studies have found that laminitis prone ponies have a different meta-
bolic profile compared to non-laminitic ponies with significantly higher BCS, 
plasma insulin concentrations as well as decreased cortisol concentrations (Kibby 
et al. 2006; Bailey et al. 2008). The metabolic profile and the predisposition for 
laminitis also seem to be inherited (Kibby et al. 2006). It is possible that the dif-
ferences reported in plasma ET-1 and serum cortisol between breeds also are in-
herited and part of a metabolic profile associated with EMS. However, this must 
be further investigated on a larger material of horses of different breeds.  
 
In conclusion, indirect blood pressure measurement, plasma ET-1 and serum corti-
sol all showed an acceptable day-to-day variation and are candidates for further 
investigation in horses with Equine metabolic syndrome. Both the Cardell and the 
HDO device can be used for measurement of indirect blood pressure in horses, but 
the HDO device was most practical to handle, especially in a field setting. There 
seem to exist a breed difference in the concentrations of plasma ET-1 and serum 
cortisol, and that has to be considered if one intends to use these parameters in 
clinical settings. There are indications that test results can be influences by trans-
portation and housing in a new environment, as was the case with ET-1 in the pre-
sent study. Future studies that investigate the possible seasonal variation in blood 
pressure, ET-1 and cortisol on healthy horses of different breeds and of horses 
clinically affected of EMS are desirable.  
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